Your browser doesn't support javascript.
loading
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
Tanaka, Yoshiya; Fautrel, Bruno; Keystone, Edward C; Ortmann, Robert A; Xie, Li; Zhu, Baojin; Issa, Maher; Patel, Himanshu; Gaich, Carol L; de Bono, Stephanie; Rooney, Terence P; Taylor, Peter C.
Afiliação
  • Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan tanaka@med.uoeh-u.ac.jp.
  • Fautrel B; Dept of Rheumatology, Sorbonne Universite,Pierre Louis Institute of Epidemiology and Public Health, Pépites team; APHP, GH Pitie Salpetriere, Paris, France.
  • Keystone EC; Rebecca MacDonald Centre for Arthritis and Autoimmune Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Ortmann RA; University of Toronto, Toronto, Ontario, Canada.
  • Xie L; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Zhu B; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Issa M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Patel H; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Gaich CL; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • de Bono S; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Rooney TP; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Taylor PC; Eli Lilly and Company, Indianapolis, Indiana, USA.
Ann Rheum Dis ; 78(7): 890-898, 2019 07.
Article em En | MEDLINE | ID: mdl-31040122

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sulfonamidas / Azetidinas / Antirreumáticos / Adalimumab Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sulfonamidas / Azetidinas / Antirreumáticos / Adalimumab Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article